| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.3 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |